Acuta Capital Partners’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-232,896
Closed -$6.65M 53
2021
Q2
$6.65M Sell
232,896
-54,104
-19% -$1.57M 2.85% 12
2021
Q1
$8.34M Buy
+287,000
New +$6.67M 3.01% 11
2017
Q3
Sell
-22,100
Closed -$242K 72
2017
Q2
$242K Sell
22,100
-8,165
-27% -$267K 0.1% 56
2017
Q1
$1.88M Hold
30,265
0.68% 40
2016
Q4
$1.33M Buy
30,265
+930
+3% +$40.5K 0.53% 32
2016
Q3
$1.68M Buy
29,335
+823
+3% +$44K 0.69% 39
2016
Q2
$1.75M Buy
28,512
+5,145
+22% +$321K 0.88% 34
2016
Q1
$1.52M Buy
23,367
+7,242
+45% +$472K 0.88% 28
2015
Q4
$1.48M Buy
16,125
+1,705
+12% +$178K 0.79% 35
2015
Q3
$1.8M Buy
+14,420
New +$2.01M 1.14% 34

Other funds holding EPIX